Peer-reviewedCC BYJournal of clinical apheresis
Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE)
5 affiliations
- 1Medical University Vienna
- 2Center for Oncology and Hematology, Clinic Ottakring
- 3Medical University of Graz
- 4Clinic Donaustadt
- 5Medical University of Vienna
Related
- Stem cell mobilization with G-CSF and on-demand plerixafor in newly diagnosed multiple myeloma patients treated with daratumumab: a single-center experience
- Risk-tailored antiemetic prophylaxis with NEPA in Chinese cancer patients receiving moderately emetogenic chemotherapy : MyRisk study subgroup analysis
- Associations between a series of composite glucose-lipid indices and moderately increased albuminuria in patients with type 2 diabetes mellitus: a cross-sectional study
- Spatial mapping of loco regional recurrences and disease related outcomes in breast cancer patients with Internal Mammary Node (IMN) positivity at presentation treated with a curative intent using moderately hypo-fractionated radiotherapy
- A randomized controlled trial of a multidisciplinary collaborative fatigue management program for patients undergoing hematopoietic stem cell transplantation: study protocol
BibTeX
@article{nina2026plerixafor,
title = {{Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE)}},
author = {Worel Nina and Schreder Martin and Tanzmann Andreas and Kurz Martin and Huber‐Kraßnitzer Bianca and Neumeister Peter and Rosskopf Konrad and Sareban Nazanin and Branka Manuela and Kolovratova Vera and Oesterreicher Sophia and Koerbler Beatrix and Kitzweger Elvira and Ruckser Reinhard and Rabitsch Werner and Agis Hermine and Krauth Maria and Greinix Hildegard T.},
journal = {Journal of clinical apheresis},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13658576},
note = {CC BY},
}
RIS
TY - JOUR
TI - Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE)
AU - Worel Nina
AU - Schreder Martin
AU - Tanzmann Andreas
AU - Kurz Martin
AU - Huber‐Kraßnitzer Bianca
AU - Neumeister Peter
AU - Rosskopf Konrad
AU - Sareban Nazanin
AU - Branka Manuela
AU - Kolovratova Vera
AU - Oesterreicher Sophia
AU - Koerbler Beatrix
AU - Kitzweger Elvira
AU - Ruckser Reinhard
AU - Rabitsch Werner
AU - Agis Hermine
AU - Krauth Maria
AU - Greinix Hildegard T.
PY - 2026
DA - 2026/10/01
JO - Journal of clinical apheresis
UR - https://europepmc.org/article/PMC/PMC13658576
SN - 0733-2459
SN - 1098-1101
ER -